Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. TREX
4. BAC
5. SPCX
6. SPY
7. WFC
8. ERAS
9. SPRO
10. TSCO

Go back to Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
(NASDAQ: PSTV) Delayed: 4.35 +0.18 (4.32%)
Previous Close $4.17    52 Week High $ 
Open $4.25    52 Week Low $ 
Day High $4.41    P/E N/A 
Day Low $4.14    EPS $ 
Volume 85,514